How has been the historical performance of Maximus Interna.?

Nov 09 2025 10:48 PM IST
share
Share Via
Maximus Interna. has experienced significant growth in net sales and profitability, with net sales increasing from 30.74 Cr in March 2020 to 156.85 Cr in March 2025, and profit after tax rising from 2.71 Cr to 9.10 Cr in the same period, despite negative cash flow from operating activities. Total assets and liabilities also grew substantially, reflecting the company's upward trajectory.
Answer:
The historical performance of Maximus Interna. shows a significant upward trend in net sales and profitability over the years, culminating in the latest figures for March 2025. Breakdown: Maximus Interna. has demonstrated robust growth in net sales, increasing from 30.74 Cr in March 2020 to 156.85 Cr in March 2025. This growth is accompanied by a rise in total operating income, which reached 156.85 Cr in March 2025, up from 30.74 Cr in March 2020. The company's total expenditure has also increased, amounting to 143.55 Cr in March 2025, reflecting higher raw material costs and other operating expenses. Operating profit, excluding other income, improved to 13.30 Cr in March 2025 from just 2.99 Cr in March 2020, while the overall operating profit, including other income, reached 15.20 Cr. Profit before tax has shown a steady increase, reaching 10.34 Cr in March 2025, compared to 3.07 Cr in March 2020. Consequently, profit after tax also rose to 9.10 Cr in March 2025 from 2.71 Cr in March 2020. The company's total assets have grown significantly, reaching 133.00 Cr in March 2025, up from 42.52 Cr in March 2020, while total liabilities increased to 133.00 Cr from 42.52 Cr in the same period. Cash flow from operating activities has been negative in recent years, with a cash flow of -14.00 Cr in March 2025, but financing activities have provided a net inflow of 22.00 Cr. Overall, Maximus Interna. has shown a strong upward trajectory in sales and profitability, despite challenges in cash flow management.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Maximus International Ltd Falls to 52-Week Low of Rs.9.65
Jan 29 2026 10:06 AM IST
share
Share Via
Maximus International Ltd is Rated Sell
Jan 28 2026 10:10 AM IST
share
Share Via
Maximus International Ltd Falls to 52-Week Low of Rs.9.7
Jan 28 2026 10:00 AM IST
share
Share Via
Maximus International Ltd Falls to 52-Week Low of Rs.9.71
Jan 27 2026 11:20 AM IST
share
Share Via
Why is Maximus International Ltd falling/rising?
Jan 14 2026 12:50 AM IST
share
Share Via
Maximus International Ltd is Rated Sell
Jan 05 2026 10:13 AM IST
share
Share Via
Most Read
Saboo Sodium Chloro Ltd is Rated Sell
51 minutes ago
share
Share Via
Jenburkt Pharmaceuticals Ltd. is Rated Sell
51 minutes ago
share
Share Via
iStreet Network Ltd is Rated Sell
51 minutes ago
share
Share Via
Emmbi Industries Ltd is Rated Sell
51 minutes ago
share
Share Via
Cohance Lifesciences Ltd is Rated Sell
51 minutes ago
share
Share Via
Vivo Bio Tech Ltd. is Rated Strong Sell
51 minutes ago
share
Share Via